​[CysCys21] Atrial Natriuretic Factor (3-28), Rat CAS NO.90984-99-9

​[CysCys21] Atrial Natriuretic Factor (3-28), Rat CAS NO.90984-99-9

​[CysCys21] Atrial Natriuretic Factor (3-28), Rat CAS NO.90984-99-9

​[CysCys21] Atrial Natriuretic Factor (3-28), Rat CAS NO.90984-99-9

​[CysCys21] Atrial Natriuretic Factor (3-28), Rat CAS NO.90984-99-9

[CysCys²¹] Atrial Natriuretic Factor (3‑28), Rat is a synthetic, site-specifically modified analog of rat ANF(3‑28) designed for conjugation and structural studies. This research-grade peptide features a Cys-Cys substitution at position 21, introducing an additional thiol pair while retaining the native disulfide bridge essential for receptor binding. Supplied as a lyophilized powder with ≥95% HPLC purity and low endotoxin levels, it enables site-directed labeling with fluorophores, biotin, or other probes for tracking, pull-down assays, and structural investigations of natriuretic peptide signaling pathways.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
[CysCys21] Atrial Natriuretic Factor (3-28), Rat
CAS NO.
90984-99-9
Appearance
White to off-white lyophilized powder
Molecular Formula
C119H189N43O36S2
Molecular Weight
 2862.2g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, phosphate‑buffered saline (PBS), or dilute acetic acid (e.g., 0.1 % v/v). For best results, first dissolve in a small volume of 0.1 % acetic acid or sterile water to prepare a 0.1‑1.0 mg/mL stock solution, then dilute with assay buffer

Endotoxin< 1.0 EU/mg
Biological Activity
This analog of rat ANF(3‑28) retains the ability to bind to natriuretic peptide receptors (primarily NPR‑A) and stimulate guanylyl cyclase activity, leading to increased intracellular cGMP levels. The Cys‑Cys substitution at position 21 may be designed to introduce a reactive thiol pair for conjugation, labeling, or structural studies. Bioactivity should be confirmed by cGMP accumulation or vascular relaxation assays.
Storage Conditions
Lyophilized powder: Store desiccated at –20 °C or below, protected from light.
Reconstituted solution: Aliquot and store at ≤ –20 °C; avoid repeated freeze‑thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

The peptide functions as a ligand for natriuretic peptide receptors, primarily NPR‑A, by binding to the extracellular domain through its conserved disulfide-constrained core structure. This interaction activates membrane-bound guanylyl cyclase, increasing intracellular cyclic GMP (cGMP) levels and subsequently activating cGMP-dependent protein kinases. The resulting signaling cascade promotes vasodilation, natriuresis, and diuresis, while inhibiting the renin–angiotensin–aldosterone system. The [CysCys²¹] modification does not disrupt this canonical pathway but provides a reactive handle for covalent conjugation without compromising receptor engagement in appropriate assay systems.


2.PRODUCT INDICATIONS

This modified ANF analog is indicated exclusively for research use in preclinical studies of natriuretic peptide receptor biology and probe development. It is employed as a scaffold for site-specific conjugation to fluorophores, biotin, or other tags to generate labeled ligands for receptor imaging, flow cytometry, immunohistochemistry, and pull-down assays. The unlabeled peptide serves as a cold competitor in displacement studies and can be used in functional assays to assess cGMP accumulation and vascular responses. It is not intended for diagnostic, therapeutic, or clinical applications in humans or animals.


3.CLINICAL EFFICACY OF PRODUCT

As a research reagent and conjugation scaffold, [CysCys²¹] Atrial Natriuretic Factor (3‑28), Rat has no established clinical efficacy for therapeutic use. The product has not undergone clinical development, regulatory approval, or safety evaluation for any medical indication. While it contributes to the development of molecular probes and tools for studying cardiovascular and renal diseases, its utility is confined to laboratory research. There are no proven clinical benefits or safety data supporting its use in human patients.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.